Therapeutische Strategien bei der diabetischen Neuropathie: Pathogenetisch begründbare Therapieansätze der peripheren, sensiblen, symmetrischen Neuropathie

Medizinische Klinik

Volumn 91, Issue 5, 1996, Pages 295-301

  Luft, Dieter ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

ANIMAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; NEUROLOGIC EXAMINATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANIMALS; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; HUMANS; HYPOGLYCEMIC AGENTS; NEUROLOGIC EXAMINATION; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS;

EID: 0030585161     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Altenkirch, H., G Stoltenburg-Didinger, H M Wagner, J Herrmann, G. Walter: Effects of lipoic acid in hexacarbon-induced neuropathy Neurotoxicol Teratol 12 (1990), 619-622
2. Bock, E . J Schneeweiss Ein Beitrag zur Therapie der Neuropathia diabetica Munch med Wschr. 101 (1959), 1911-1912
3. Boulton, A. J. M , S Levin, J. Comstock A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetica neuropathy. Diabetologia 33 (1990), 431-437.
4. Brownlee, M. Glycation products and the pathogenesis of diabetic complications Diabetes Care 15 (1992), 1835-1843
5. Bucala, R , K J Tracey, A Cerami. Advanced glycosylanon products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes J. clin. Invest. 87 (1991), 432-438.
6. Cameron, N E , M A Cotter Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy evidence from experimental studies. Diabet Med 10 (1993), 593-605
7. Cameron, N. E , M. A. Cotter, K Dines, A Love Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats Diabetologia 35 (1992), 946-950
8. Cicmir, I , P Mayer, D Ziegler, F. A. Gries Kochdosierte Thioctsäure-Infusionstherapie mit anschließender oraler Erhaltungstherapie bei diabetischer Polyneuropathie In: Borbe, H O , H Ulrich (Hrsg.) Neue biochemische, pharmakologische und klinische Erkenntnisse zur Thioctsäure pmi-Verlag, Frankfurt/ Main 1989, S. 311.
9. Clements, R. S , B. Vourganti, T Kuba, S J. Oh, S Darnell Dietary myo-inositol intake and peripheral nerve function in diabetic neuropathy. Metabolism 28, Suppl. 1 (1979), 477-483
10. Comi, G , G. Galardi, S. Amadio, E Bianchi, A. Secchi, S. Martinenghi, R. Caldara, G Pozza, N Canal: Neurophysiological study of the effect of combined kidney and pancreas transplantation on diabetic neuropathy a 2-year follow-up evaluation Diabetologia 24. Suppl 1 (1991), S103-S107.
11. Dahl-Jørgensen, K , O Brinchmann-Hansen, K F Hanzen, T. Ganes, P. Kierulf, E Smeland, L. Sandvik, O. Aagenaes Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Brit. med J 293 (1986), 1195-1199.
12. Delcker, A , P -A. Fischer, H. Ulrich: Randomisierre Studie Thioctsaure gegenuber Vitamm-B-Kombinationspraparat bei Pattenten mit diabetischer Polyneuropathie unter besonderer Berücksichtigung des peripheren Nervensystems. In. Borbe, H O., H. Ulrich (Hrsg) Neue biochemische, pharmakologische und klinische Erkenntnisse zur Thioctsäure. pmi-Verlag, Frankfurt/Main 1989, S. 335-344
13. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl. J Med. 329 (1993), 977-986
14. Di Giulio, A M , A Gono, A Bertelli, P Mantegazza, L. Ferraris, M T Ramacci Acetyl-L-camitine prevents substance P loss in the sciatic nerve and lumbar spinal cord of diabetic animals Int J clin pharm Res 12 (1992), 243-246
15. Gallai, V , G Mazzotta, S. Montesi, P Sarchielli, F del Gatto: Effects of uridine in the treatment of diabetic neuropathy an electrophysiological study. Acta neurol scand. 86 (1992), 3-7.
16. Gamma-linolenic acid multicenter trial group Treatment of diabetic neuropathy with γ-linolenic acid. Diabetes Care 16 (1993), 8-15.
17. Giugliano, D , R Marfella, A Quatraro, N de Rosa, T. Salvatore, D. Cozzolino, A Cenello, R Torella Tolrestat for mild diabetic neuropathy. A 52-week, randomized, placebo-controlled trial Ann. intern Med 118 (1993), 7-11
18. Gono, A , A M Di Giulio, B. Tenconi, L Donadom, E. Germani, A Bertelli, P Mantegazza, F Maccan, M T. Ramacci Peptide alterations in autonomic diabetic neuropathy prevented by acetyl-L-camitine Int J clin pharin. Res 12 (1992), 225-230.
19. Gregersen, G , B. Bertelsen, H Harbo, E Larsen, J R Andersen, A Helles, M Schmiegelow, J. E J Christensen: Oral supplementation of myoinositol: effects on peripheral nerve function in human diabetics and on the concentration in plasma, erythrocytes, urine and muscle tissue in human diabetics and normals. Acta neurol scand 67 (1983), 164-172.
20. Gregersen, G , H Borsting, P. Theil, C Servo: Myoinositol and function of peripheral nerves in human diabetics A controlled clinical trial Acta neurol. scand. 58 (1978), 241-248
21. Greene, D. A Effects of aldose reductase inhibitors on the progression of nerve fiber damage in diabetic neuropathy. J Diabet Compl 6 (1992), 35-38
22. +-ATPase regulation involved in pathogenesis of diabetic neuropathy? Diabetes 37 (1988), 688-693
23. Greene, D A , A A F Sima, M J Stevens, E. L Feldman, S A. Lattimer: Complications, neuropathy, pathogenetic considerations. Diabetes Care 15 (1992), 1902-1925.
24. Holman, R. R , T L Dornan, V Mayon-White, J. Howard-Williams, C. Orde-Peckar, L Jenkins, J. Steemson, R. Rolfe, B. Smith, D Barbour, K McPherson, P Poon, C Rizza, J I. Marin, A. H Knight, A. J. Bron, R C. Turner Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients A two-year randomized prospective study Lancet 1 (1983), 204-208
25. Horrobin, D. F . The effects of gamma-linolenic acid on breast pain and diabetic neuropathy: possible non-eicosanoid mechanisms. Prostaglandin. Leukotr essent fatty Acids 48 (1993), 101-104
26. Jakobsen, J., J S. Christiansen, I Kristoffersen, C K Christensen, K. Hermansen, A. Schmitz, C E Mogensen Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type I diabetes Diabetes 37 (1988), 452-455
27. Jamal, G A Pathogenesis of diabetic neuropathy The role of the n-6 essential fatty acids and their eicosanoid derivatives Diabet Med. 7 (1990), 574-579
28. Jamal, G A , H Carmichael. The effect of γ-linolenic acid on human diabetic peripheral neuropathy a double-blind placebo-controlled trial. Diabet. Med 7 (1990), 319-323
29. Jorg, J., F Metz, H Scharafinski Zur medikamentosen Behandlung der diabetischen Polyneuropathie mit der Alpha-Liponsäure oder Vitamin-B-Praparaten Nervenarzt 59 (1988), 36-44.
30. Kähler, W , B Kuklinski, C Ruhlman, C Plötz Diabetes mellitus - eine mit Freien Radikalen assoziterte Erkrankung. Resultate einer adjuvanten Antioxidantiensupplementation. Z. ges. inn. Med 48 (1993), 223-232
31. Kemplay, S , P. Martin, S Wilson. The effects of thioctic acid on motor nerve terminals in acrylamide poisoned rats. Neuropath appl Neurobiol. 14 (1988), 275-288
32. Kennedy, W. R , X. Navarro, F C Goetz, D. E. R. Sutherland, J. S. Najariari Effects of pancreatic transplantation on diabetic neuropathy. New Engl. J Med. 322 (1990), 1033-1037.
33. Kihara, M., J. D. Schmelzer, J. F. Poduslo, G. L. Curran, K K Nickander, P. A Low. Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals Proc. nat Acad Sci (Wash.) 88 (1991), 6107-6111.
34. Klein, W. Die Behandlung der Neuropathia diabetica mit oralen Gaben von Alpha-Liponsäure Munch med. Wschr 117 (1975), 957-958.
35. Krans, H. M. J Recent clinical experience with aldose reductase inhibitors. J Diabet Compl 6 (1992), 39-44.
36. Launtzen, T , K. Frost-Larsen, H.-W Larsen, T. Deckert, the Steno Study Group. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy Diabetes 34, Suppl. 3 (1985), 74-79
37. Lowitt, S , J I Malone, A Salem, W M. Kozak, Z. Orfalian: Acetyl-L-Carnitine corrects electroretinographic deficits in experimental diabetes. Diabetes 42 (1993), 1115-1110
38. MacLeod, A F., A J M. Boulton, D. R Owens, P van Rooy, J. M. A. van Gerven, S Macrury, J H B Scarpello, O Segers, S. R. Heller, E A van der Veen, and the North European Tolrestat Study group. A multicentre trial of the aldose-reductase inhibitor tolrestat, in patients with symptomatic diabetic peripheral neuropathy. Diabet Metab 18 (1992), 14-20
39. Malone, J. I , S. Lowitt, N Corsica, Z Orfalian Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-Carnitine Int J clin pharm Res 32 (1992), 237-241
40. Masson, E. A., A. J. M Boulton Aldose reductase inhibitors in the treatment of diabetic neuropathy A review of the rationale and clinical evidence Drugs 39 (1990), 190-202.
41. Mayer, P., I Cicmir, D Ziegler, F A Gries: Ist die hochdosierte parenterale Langzeittherapie mit Thioctsäure oder Vitamin B1 bei Patienten mit diabetischer Polyneuropathie sinnvoll? Akt. Endokr. Stoffw 7 (1986), 94.
42. Morabico, E., S. Serafini, N Corsico, E. Amgoni Martelli: Acetyl-L-carnitine effect on nerve conduction velocity in streptozotocin-diabetic rats Arzneimittel-Forsch 43 (1993), 343-346
43. Muller-Felber, W , R Landgraf, R Scheuer, S. Wagner, C D Reimers, J. Nusser, D Abendroth, W D Illner, W. Land: Diabetic neuropathy 3 years after successful pancreas and kidney transplantation. Diabetes 42 (1993), 1482-1486.
44. Naouri, A , X Martin, J M Dubernard Evolution of diabetic neuropathy after kidney-pancreas transplantation Transplant Proc. 24 (1992), 875-876.
45. Packer, L The role of anti-oxidative treatment in diabetes mellitus (workshop report) Diabetologia 36 (1993), 1232-1213
46. Reichard, P , B Y Nilsson, U. Rosenqvist The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. New Engl J Med 329 (1983), 304-309.
47. Reschke, B.: Trendanalyse zu einer Langzeitstudie mit Thioctacid R bei diabetischer Polyneuropathie. Ergebnisse bei auronomer Polyneuroparhie aus internistischer Sicht. In Neundorfer, B , D Sailer (Hrsg): Interdisziplinare Bestandsaufnahme der Polyneuropathien. Perimed, Erlangen 1986, S 188-196.
48. Reschke, B , S Zeuzem, C Rosak, R. Petzoldt, P H. Althoff, H. Ulrich, K Schöffling Hochdosierte Langzeitbehandlung mit Thioctsaure bei der diaberischen Polyneuropathie - Ergebnisse einer kontrollicrten, randomisierten Studie unter besonderer Berucksichtigung der autonomen Neuropathie In Borbe, H O., H. Ulnch (Hrsy). Neue biochemische, pharmakologische und klinische Erkenntnisse zur Thioctsaure. pmi-Verlag, Frankfurt/Main 1989, S 318-334.
49. Sachse, G , B. Willms Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy. Horm Metab Res 9, Suppl. (1980), 105-108.
50. Salway, J G , L Whitehead, J. A Finnegan, A. Karunanayaka, D Barnett, R B Payne. Effect of myo-mositol on peripheral-nerve function in diabetes Lancet 2 (1978), 1282-1284.
51. Santiago, J. V., P H. Sonksen, A. J M Boulton, A. Macleod, M Beg, W. Bochenek, G J. Graepel, B. Gonen, the Tolrestat Study Group: Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy, effect on nerve function. J Diabet. Compl 7 (1993), 170-178.
52. Schmidt, R E. The role of nerve growth factor in the pathogenesis and therapy of diabetic neuropathy. Diabet Med 10, Suppl 2 (1993), 10S-13S
53. Schönbrunn, E , P. A Fischer, T Brand, M. Hahn. Trendanalyse zu einer Langzeitstudie mit Thioctacid R bei diabetischer Polyneuropathie. Ergebnisse bei peripherer diabetischer Polyneuropathie aus neurologischer Sicht. In Neundorfer, B , D Sailer (Hrsg.): Interdisziplinäre Bestandsaufnahme der Polyneuropathien Perimed, Erlangen 1986, S 197-204
54. Schreiber, F -K : Zur Behandlung der Neuropathia diabetica. Dtsch. med Wschr 86 (1961), 531-536
55. Schulz, D , G. Reichel, I. Huttl, E Zander, U, Runge Zur Wirksamkeit der Thioctsauretherapie bei Typ-1-Diabetikern Wiss Z Ernst-Montz-Amdt-Univ. Greifswald, Med Reihe 35 (1986), 48-50
56. Schwick, W., Die diabetische Neuropathie und ihre Behandlung mit Thioctsaure Therapiewoche 25 (1975), 3263-3266.
57. Sima, A A F., D. A Greene, M. B Brown, T C. Hohman, D. Hicks, G J., Graepel, W J Bochenek, M Beg, D Gonen, the Tolrestat study group: Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral poly neuropathy J Diabet Compl. 7 (1993), 157-169
58. Solders, G , G Tydén, A Persson, C G Groth Improvement of nerve conduction in diabetic neuropathy. A follow-up study 4yr after combined pancreatic and renal transplantation Diabetes 41 (1992), 946-951
59. Stracke, H., E Dietrich, K Federlin Anderung subjektiver Beschwerden und objektiver Meßgrößen bei 19 Diabetikern unter der Therapie mit Thioctsaure. In Borbe, H O , H. Ulrich (Hrsg.): Neue biochemische, pharmakologische und klinische Erkenntnisse zur Thioctsäure pmi-Verlag, Frankfurt/Main 1989, S. 350-356
60. Studt, J , L. J. Heuer Die diabetische autonome Neuropathic des Herzens und ihre Behandlung mit Thioctsäure Dtsch Z Verdau Stoffwechselkr 44 (1984), 173-180
61. Tomlinson, D R Polyols und myo-inositol in diabetic neuropathy - of mice and men. Mayo Clin Proc 64 (1989), 1030-1033.
62. Tomlinson, D R : The pharmacology of diabetic neuropathy Diabet. Metab. Rev 8 (1992), 67-84
63. Tomlinson, D R : Aldose reductase inhibitors and the complications of diabetes mellitus Diabet Med 10 (1993), 214-230
64. Valensi, P , J -R. Attali, S. Gagant, and the French Group for Research and Study of Diabetic Neuropathy Reproducibility of parameters for assessment of diabetic neuropathy Diabet Med 10 (1993), 933-939
65. Vinik, A I , M. T Holland, J. M. LeBeau, F J. Liuzzi, K. B. Stansberry, L B Colen: Diabetic neuropathies Diabetes Care 15 (1992), 1926-1975.
66. +-ATPase impairment in experimental diabetes Diabet Nutt Metab 5 (1992), 31-36
67. Watkins, P J. Clinical observations and experiments in diabetic neuropathy. Diabetologia 35 (1992), 2-11.
68. Yagihashi, S , M Kamijo, M Baba, N. Yagihashi, K. Nagai: Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 41 (1992), 47-52.
69. Ziegler, D , P. Mayer, H Muhlen, F A. Gries. Effekte einer Therapie mit Alpha-Liponsaure gegenuber Vitamin B1 bei der diabetischen Neuropathie. Diabetes u. Stoffw. 2 (1993), 443-448
70. Ziegler, D , H J Muhlen, W. Rathmann, F A Gries Effekte einer einjährigen Therapie der diabetischen Neuropathie mit Gamma-Linolensaure (abstract) Diabetes u Stoffw 2 (1994), 211.